Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−209.13 M USD
0.00 USD
60.07 M
About Metsera, Inc.
Sector
Industry
CEO
Christopher Whitten Bernard
Website
Headquarters
New York
Founded
2022
FIGI
BBG01MJLWZG3
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of MTSR is 18.02 USD — it has decreased by −10.18% in the past 24 hours. Watch Metsera, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Metsera, Inc. stocks are traded under the ticker MTSR.
MTSR stock has risen by 20.96% compared to the previous week, the month change is a −28.97% fall, over the last year Metsera, Inc. has showed a −29.33% decrease.
We've gathered analysts' opinions on Metsera, Inc. future price: according to them, MTSR price has a max estimate of 56.00 USD and a min estimate of 38.00 USD. Watch MTSR chart and read a more detailed Metsera, Inc. stock forecast: see what analysts think of Metsera, Inc. and suggest that you do with its stocks.
MTSR reached its all-time high on Feb 19, 2025 with the price of 32.81 USD, and its all-time low was 12.30 USD and was reached on Apr 9, 2025. View more price dynamics on MTSR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MTSR stock is 24.91% volatile and has beta coefficient of 1.73. Track Metsera, Inc. stock price on the chart and check out the list of the most volatile stocks — is Metsera, Inc. there?
Today Metsera, Inc. has the market capitalization of 2.22 B, it has increased by 39.79% over the last week.
Yes, you can track Metsera, Inc. financials in yearly and quarterly reports right on TradingView.
Metsera, Inc. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
MTSR earnings for the last quarter are −3.52 USD per share, whereas the estimation was −0.61 USD resulting in a −477.05% surprise. The estimated earnings for the next quarter are −0.94 USD per share. See more details about Metsera, Inc. earnings.
Metsera, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MTSR net income for the last quarter is −52.87 M USD, while the quarter before that showed −13.03 M USD of net income which accounts for −305.79% change. Track more Metsera, Inc. financial stats to get the full picture.
No, MTSR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 25, 2025, the company has 81 employees. See our rating of the largest employees — is Metsera, Inc. on this list?
Like other stocks, MTSR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Metsera, Inc. stock right from TradingView charts — choose your broker and connect to your account.